Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
702
591
492
410
322
265
Hasılat Artışı (YoY)
25%
20%
20%
27%
22%
24%
Satınalma Maliyeti
208
184
160
129
109
70
Brüt Kâr
494
407
331
281
213
194
Satış, Genel ve İdari
465
407
369
322
274
197
Araştırma ve Geliştirme
82
71
60
46
38
41
İşletme Giderleri
548
478
430
368
313
238
Diğer Finansman Gelirleri (Giderleri)
4
1
6
2
0
1
Kâr Öncesi Gelir
-50
-112
-122
-115
-101
-43
Kira Vergisi Gideri
0
0
0
0
0
0
Net Kâr
-51
-113
-123
-116
-101
-43
Net Income Growth
Kâr Artışı
-66%
-8%
6%
15%
135%
-20%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
32.17
31.19
30.52
29.9
29.3
27.8
Hisse Değişimi (Yıllık Üst Üste)
3%
2%
2%
2%
5%
10%
EPS (Diluted)
-1.59
-3.63
-4.04
-3.88
-3.46
-1.58
EPS Artışı
-67%
-10%
4%
12%
119%
-27%
Öz sermaye akışı
32
-45
-90
-52
-65
-27
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
70.37%
68.86%
67.27%
68.53%
66.14%
73.2%
Faaliyet Kâr Marjı
-7.54%
-12.01%
-19.91%
-21.21%
-30.74%
-16.22%
Kâr Marjı
-7.26%
-19.12%
-25%
-28.29%
-31.36%
-16.22%
Özsermaye Karlılık Oranı
4.55%
-7.61%
-18.29%
-12.68%
-20.18%
-10.18%
EBITDA
-33
-51
-82
-74
-90
-37
EBITDA Marjinali
-4.7%
-8.62%
-16.66%
-18.04%
-27.95%
-13.96%
D&A EBITDA için
20
20
16
13
9
6
Faaliyet Kârı
-53
-71
-98
-87
-99
-43
Faaliyet Kâr Marjı
-7.54%
-12.01%
-19.91%
-21.21%
-30.74%
-16.22%
Verilen Vergi Oranı
0%
0%
0%
0%
0%
0%
Önemli İstatistikler
Önceki Kapanış
$148.41
Açılış fiyatı
$148.42
Günün Aralığı
$143.94 - $150.29
52 haftalık aralık
$92.52 - $212
İşlem hacmi
455.3K
Ort.Hacim
523.4K
EPS (TTM)
-1.62
Dividend yield
--
Piyasa Değeri
$4.6B
IRTC nedir?
iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. The company is headquartered in San Francisco, California and currently employs 2,000 full-time employees. The company went IPO on 2016-10-20. The company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. The company offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. The company offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services, using its Zio Systems. The Zio Monitor System is a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for over 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.